Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05274321 · ClinicalTrials.gov registry record · NA
Efficacy of the Nanodropper Device on Pupillary Dilation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05274321 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 50 participants.
The verdict
NCT05274321, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.
Interventions
- DEVICE Nanodropper
- DEVICE Standard Eye Dropper
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-07-29 |
| Est. Completion | 2021-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05274321
The ClinicalTrials.gov registry entry for NCT05274321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nanodropper is the first listed.
NCT05274321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05274321 about?
NCT05274321 is a clinical study titled "Efficacy of the Nanodropper Device on Pupillary Dilation". Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.
What is the current status of trial NCT05274321?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-07-29. Estimated completion is 2021-11-19.
What interventions are being tested in trial NCT05274321?
The interventions under investigation include: Nanodropper (DEVICE), Standard Eye Dropper (DEVICE).
Who is sponsoring clinical trial NCT05274321?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.